Inve US ▾
NGNGVT

Ingevity (NGVT) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Materials· Jul 30, 2026

Source: earnings call transcript

Executive summary

Ingevity Q2 FY26 — Strong Performance, Raised Outlook, and Portfolio Transformation Progress

Ingevity delivered a strong second quarter, marked by significant adjusted EBITDA and EPS growth, driven by portfolio optimization and operational excellence across all segments. The company raised its full-year outlook, reflecting confidence in its strategy, while continuing to advance the strategic review of Advanced Polymer Technologies and executing on its share repurchase commitment.

Highlights

5
  • Sales, excluding the Road Markings divestiture, increased 5% with growth across all 3 segments.

  • Adjusted EBITDA increased nearly 14% to $115 million, with margins expanding to 36.6%.

  • Performance Materials delivered exceptional results with EBITDA margins approaching 54%.

  • Adjusted EPS increased to $1.74, benefiting from stronger operating performance, lower interest expense, and reduced share count.

  • Net leverage improved to 2.5x, reaching the upper end of the target range.

Concerns

3
  • Pavement Technologies faced headwinds from softer demand in China and South America due to higher asphalt prices impacting project costs and causing delays.

  • Expected normalization of Performance Materials plant utilization in H2 FY26 due to lower expected auto production and planned maintenance outages.

  • The macroeconomic environment remains dynamic, influencing the cadence of H2 results.

Guidance & targets

CategoryTargetConfidence
Full-year Adjusted EBITDA
$380 million to $400 million
high materiality
High
Full-year Adjusted Earnings Per Share
$5.00 to $5.45
high materiality
High
Full-year Free Cash Flow
$220 million to $245 million
medium materiality
High
Share Repurchase Program
$300 million
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
Performance Materials
Driven by higher volumes, favorable mix (shift to hybrid vehicles), and annual pricing actions. Strong plant utilization and solid demand. Expects normalization of plant utilization in H2 due to lower auto production and planned maintenance.
Segment EBITDA: $86 million
$161 million4%—53.6% EBITDA margin
Pavement Technologies
Renamed from Performance Chemicals. Reported sales declined 22% due to Road Markings divestiture. Excluding divestiture, sales increased due to favorable pricing and volume growth, led by North America. Partially offset by softer demand in China and South America due to higher asphalt prices. EBITDA margin expanded 300 bps ex-Road Markings.
Segment EBITDA: declined by $3.4 million (reported)Road Markings earnings in prior year: ~$6 millionEvotherm growth: 8% YoY
—3% (excluding Road Markings)—24.4% EBITDA margin (excluding Road Markings impact)
Advanced Polymer Technologies
Meaningful year-over-year improvement. Benefited from pricing surcharges, improved mix towards higher-value derivative products, higher asset utilization, and absence of 2025 operational downtime. Also benefited from competitor supply disruptions due to Middle East conflict, which has normalized. Strategic alternatives process is in advanced stage.
Segment EBITDA: $11 million
$49 million14%—22.7% EBITDA margin

Product announcements

ProductTypeDetails
PFAS Filtration Technologymilestone

Deals & partnerships

null Sale of Road Markings product line

Completed on April 15.

null Sale of Industrial Specialties business

Completed earlier this year.

null Strategic alternatives process for Advanced Polymer Technologies

Priority remains achieving the best outcome for shareholders while continuing to sharpen strategic focus.

Risks & headwinds

Lower North American auto production H2 FY26

Expected to be weaker in the back half of the year

Mitigation:Performance Materials' structural shift to hybrid vehicles (higher value product mix) provides some offset.

Planned maintenance outages at Performance Materials facilities H2 FY26

Will execute at 2 facilities

Mitigation:Factored into the updated full-year outlook and expected normalization of plant utilization.

Dynamic macroeconomic environment H2 FY26

Influences the cadence of results

Mitigation:Company is focused on commercial and operational excellence to maximize value.

Higher asphalt prices Q2 FY26 and potentially ongoing

Up almost 50%

Mitigation:Impacted international projects more significantly (e.g., China down 80%), less so North America. Evotherm technology continues to gain penetration.

Normalization of competitor supply disruptions H2 FY26

Benefited APT in Q2, now normalized

Mitigation:APT's improved mix towards higher-value derivative products and higher asset utilization are expected to support performance.

What to watch in Q3 FY26

Performance Materials Plant Utilization

H2 FY26
Current Efficient utilization in Q2 FY26
Target Normalization reflecting lower auto production and planned maintenance

Why it matters

Impacts segment profitability and overall earnings cadence.

For the remainder of the year, we expect plant utilization to normalize, reflecting lower expected auto production as well as the execution of planned maintenance outages.

Find out whether NGVT delivers this. Inve re-checks your case every morning.

Q&A highlights

How to think about short-term margins in PM given expected auto production decline and planned outages, and medium-term impact from PFAS and other opportunities.

Management expects some short-term pressure in H2 due to softer auto production and planned outages, but the structural shift to hybrids (higher-value carbon solutions) and emerging filtration opportunities are long-term positives for PM margins. Full-year PM margins are expected in the mid-50s.

“For the remainder of the year, we expect plant utilization to normalize, reflecting lower expected auto production as well as the execution of planned maintenance outages. While this dynamic benefited second quarter profitability, it represents a timing shift that is reflected in our expectations for the back half of this year.”

asked by Lee Jagoda · answered by David Li

2 min read 6 chapters

Detailed narrative

Portfolio Transformation Progress

Ingevity is nearing completion of its portfolio transformation strategy, having divested the Road Markings product line in Q2 and Industrial Specialties earlier in the year. These actions aim to improve portfolio quality and sharpen strategic focus on higher-return opportunities. The strategic alternatives process for Advanced Polymer Technologies is also in an advanced stage, with the company prioritizing the best outcome for shareholders.

Strong Operational Performance

The company delivered strong commercial and operational performance across all three segments. Excluding divestitures, sales increased 5%, and adjusted EBITDA grew nearly 14% to $115 million, with margins expanding to 36.6%. This performance was driven by higher pricing, favorable product mix, improved asset utilization, and disciplined operational execution.

Performance Materials Strength

The Performance Materials segment continued its exceptional profitability, with EBITDA margins approaching 54%. This is largely attributed to a structural shift in consumer buying habits towards hybrid vehicles, which require more advanced and higher-value carbon solutions, contributing to a favorable product mix and sustainable earnings power.

Emerging Growth Opportunities

Ingevity is seeing encouraging commercial validation for several organic growth initiatives, particularly in filtration. The company secured its first municipal water treatment contract for PFAS filtration, demonstrating differentiated performance and potential for long-term growth. Other opportunities include warm mix asphalt technologies and energy storage.

Capital Allocation and Balance Sheet

The company maintained a disciplined and balanced capital allocation strategy, repurchasing $35 million of shares in the quarter and remaining ahead of pace for its $300 million share repurchase commitment by the end of 2027. Net leverage improved to 2.5x, reaching the upper end of the target range, strengthening financial flexibility.

Updated Full-Year Outlook

Due to strong first-half execution, Ingevity raised its full-year adjusted EBITDA guidance to $380 million to $400 million and adjusted EPS to $5.00 to $5.45. The free cash flow guidance low end was also raised to $220 million to $245 million, reflecting improved earnings partially offset by higher inventory levels and seasonal builds.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.